Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 15 results found. Search for [ Dr Reddy's Q1 results ]

Results 1 to 15 of 15
BusinessToday.In
September 9, 2020
The operating income of Eveready Industries declined by 18 per cent to Rs 263.45 crore in Q1 FY21 from Rs 321.04 crore in the Q1 FY20


BusinessToday.In
July 29, 2020
Markets were also trading mixed on Wednesday, ahead of the FOMC outcome scheduled to end today. Rising coronavirus cases and ongoing tensions between the US and China also weighed on the sentiment


PTI
July 29, 2020
Revenues for the quarter under discussion was up by 15 per cent to Rs 4,417.5 crore against Rs 3,843.5 crore in Q1 of last fiscal


BusinessToday.In
July 29, 2020
India Stock Market Highlights Today: Infosys, HCL Tech, Nestle India, M&M, Reliance Industries and Tech Mahindra were among the laggards today, while IndusInd Bank, followed by UltraTech Cement, Tata Steel, Sun Pharma, L&T and ICICI Bank were among gainers.


PB Jayakumar
New Delhi, November 12, 2019
The divestment will curtail 13 per cent global revenues of Lupin, which had posted Rs 16,369 crore consolidated revenues for the financial year ended March 31, 2019


E Kumar Sharma
New Delhi, November 2, 2019
Dr Reddy's CFO Saumen Chakraborty attributed much of the challenges in the US market to price erosion and lower volumes


PB Jayakumar
October 1, 2019
The communication also directed the state-level authorities to communicate to the DCGI at the earliest on the action initiated by them.


E Kumar Sharma
September 5, 2019
Even as smaller Indian companies are looking to grow their business in the US market, the larger focus is on leading pharma companies because the top 20 of them contribute 75 per cent to total pharma exports from India


E Kumar Sharma
New Delhi, July 24, 2019
Analysts expect a better show in Q1 thanks to a combination of factors such as overall business improvement in the Unites States and a pick-up in demand in the domestic market.


E Kumar Sharma
October 26, 2018
The pharma major had posted a robust performance in the June quarter of FY19, largely aided by the launch in the US of gSuboxone, the generic version of the drug to deal opioid addiction.


E Kumar Sharma
New Delhi, July 27, 2017
While both Dr Reddy's and Glenmark took a hit from the adjustments post-GST, factors such as price erosion in the US and higher costs, brought down the former's numbers.


E Kumar Sharma
July 26, 2016
Afterall, its net profit for the quarter was down 80 per cent PAT touching Rs 126.3 crore as against Rs 625.7 crore in the corresponding period of the previous year.


E. Kumar Sharma
July 30, 2015
There were two important growth drivers for the company. One, the 8 per cent year-on-year growth in its global generics business, which were primarily driven by North America; and two, good growth shown in its India business.


PTI
Mumbai, July 24, 2015
Brokers said disappointing quarterly earnings from some bluechip companies and a weak trend at other Asian markets dampened trading sentiment here.


PTI
Mumbai, July 20, 2011
The drug firm posted a consolidated net profit of Rs 262.74 crore for the first quarter ended June 30, against Rs 209.55 crore in the same period previous year.


PAGES 1 OF 1